Logo
  • Important Safety Information
  • Prescribing Information
  • Patient Site
Logo
  • Important Safety Information
  • Prescribing Information
  • Patient Site
  • HIV Treatment
    Considerations
    DHHS Guidelines:
    Weight
    Patients at Risk:
    Weight
    Real-World Data:
    INSTI vs PI
    Patient POVDHHS Guidelines:
    Rapid Initiation
    Patients at Risk:
    HGBR
    M184V/I Prevalence
  • Efficacy
    Treatment-Naïve
    Patients
    Rapid Initiation
    Patients
    Virologically
    Suppressed Patients
  • Resistance
    Summary
  • Safety &
    Tolerability
    Adverse Event 
    Profile
    GI TolerabilityWeight ChangeReal-World Data: 
    SYMTUZA® vs 
    BIC/FTC/TAF
    Neuropsychiatric 
    Tolerability
    Patient Satisfaction
  • Dosing &
    Administration
    DosingPatient SatisfactionSTR Pill GuideCoadministrationDarunavir Dosing
    Simplified
  • Support & Treatment
    Resources
    ResourcesSYMply Start®CoverMyMeds®Request
         Samples
    Coverage in
    Your Area
    Switch DRV Patients
    to SYMTUZA®
  • Important Safety Information
  • Patient Site
  • Prescribing Information
  • Stay Connected

Coverage In Your Area

Loading...

Arrow icon

Loading...

Loading...

Loading...

Loading...

Collected in Loading... and may change.

This information is not a promise of coverage or payment. It is not intended to give reimbursement advice or increase reimbursement by any payer. Legal requirements and plan information can be updated frequently. Contact the plan for more information about current coverage, reimbursement policies, restrictions, or requirements that may apply.

Reference: Source: Managed Markets Insight and Technology, LLC™, a trademark of MMIT, as of 09/23.